SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535384-19-000009
Filing Date
2019-07-18
Accepted
2019-07-18 14:11:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G FILING OHRP sc13g-718_ohrp.htm SC 13G 41525
2 SC 13G FILING OHRP sc13g-718_ohrp.pdf SC 13G 278064
  Complete submission text file 0001535384-19-000009.txt   423088
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-82720 | Film No.: 19961107
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1825B KRAMER LANE SUITE 200 AUSTIN TX 78758
Business Address 1825B KRAMER LANE SUITE 200 AUSTIN TX 78758 512-439-8140
Kershner Trading Americas,LLC (Filed by) CIK: 0001535384 (see all company filings)

IRS No.: 262018299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G